DocSym
β
Searchsearch
Search
(Q03.1) Atresia of foramina of magendie and luschka
More details coming soon
219 744 in individuals diagnosis atresia of foramina of magendie and luschka confirmed
7 837 deaths with diagnosis atresia of foramina of magendie and luschka
4% mortality rate associated with the disease atresia of foramina of magendie and luschka
Diagnosis atresia of foramina of magendie and luschka is diagnosed Men are 11.92% more likely than Women
122 967
Men receive the diagnosis atresia of foramina of magendie and luschka
4 022 (3.3 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
96 777
Women receive the diagnosis atresia of foramina of magendie and luschka
3 815 (3.9 %)Died from this diagnosis.
Risk Group for the Disease atresia of foramina of magendie and luschka - Men and Women aged 0
In Men diagnosis is most often set at age 0-59, 70-74
Less common in men the disease occurs at Age 60-69, 75-95+Less common in women the disease occurs at Age 45-54, 75-84, 90-95+
In Women diagnosis is most often set at age 0-44, 55-74, 85-89
Disease Features atresia of foramina of magendie and luschka
Absence or low individual and public risk
Atresia of foramina of magendie and luschka - what does this mean
Atresia of foramina of magendie and luschka is a congenital disorder that occurs when the openings in the fourth ventricle of the brain, called the foramina of magendie and luschka, are blocked or closed. this blockage can lead to hydrocephalus, a buildup of cerebrospinal fluid in the brain, and can cause a variety of neurological problems.
What happens during the disease - atresia of foramina of magendie and luschka
Atresia of foramina of magendie and luschka is a congenital disorder caused by a developmental defect in the formation of the fourth ventricle. this defect results in a blockage of the foramina of magendie and luschka, which are normally open passageways between the fourth ventricle and the subarachnoid space. this blockage prevents the cerebrospinal fluid from draining properly, leading to an accumulation of fluid in the ventricles and increased pressure on the brain. this increased pressure can cause a variety of neurological symptoms, including seizures, hydrocephalus, and cognitive and motor deficits.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Neuroimaging studies (CT, MRI, and/or myelogram)
- Lumbar puncture
- Cerebrospinal fluid analysis
- Genetic testing
- Neurophysiological testing
- Angiography
- Ultrasound
- Neurodevelopmental evaluation
- Neuropsychological testing
Treatment and Medical Assistance
Main goal of the treatment: To reduce or eliminate neurological symptoms caused by Atresia of foramina of Magendie and Luschka.
- Perform a shunt procedure to divert cerebrospinal fluid from the ventricles to the peritoneal cavity.
- Administer medications to reduce the production of cerebrospinal fluid.
- Perform an endoscopic third ventriculostomy to create a new pathway for cerebrospinal fluid.
- Perform a ventriculoperitoneal shunt to divert excess cerebrospinal fluid.
- Administer medications to reduce inflammation and swelling.
- Perform a craniotomy to create a new pathway for cerebrospinal fluid.
- Administer antibiotics to prevent infection.
- Perform a lumbar puncture to remove excess cerebrospinal fluid.
- Administer steroids to reduce inflammation.
- Perform a ventriculostomy to create a new pathway for cerebrospinal fluid.
- Administer anticonvulsant medications to reduce or prevent seizures.
18 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Atresia of foramina of magendie and luschka - Prevention
The prevention of atresia of foramina of magendie and luschka involves avoiding exposure to environmental toxins, maintaining a healthy diet, and getting regular medical checkups. additionally, it is important to be aware of any family history of this condition and to discuss any concerns with a medical professional.